New hope for HIV-Positive moms: drug shields babies during birth
NCT ID NCT02245022
First seen Sep 30, 2025 · Last updated Apr 30, 2026 · Updated 34 times
Summary
This study looked at whether the HIV drug dolutegravir is safe and works well in pregnant women with untreated HIV. Sixty women in late pregnancy took either dolutegravir or standard HIV medicines. The goal was to see how the drug moves through the body and if it can reduce the risk of passing HIV to the baby during childbirth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Desmond Tutu HIV Foundation
Cape Town, Western Cape, South Africa
-
Infectious Diseases Institute
Kampala, Uganda
Conditions
Explore the condition pages connected to this study.